Literature DB >> 6491083

Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation.

W F Shen, G S Roubin, K Hirasawa, R F Uren, B F Hutton, P J Harris, P J Fletcher, D T Kelly.   

Abstract

The acute effects of nifedipine (20 mg sublingually) on hemodynamics and cardiac function were studied at rest and during supine bicycle exercise in 20 patients with aortic regurgitation. At rest, heart rate increased by 13%, systemic vascular resistance decreased by 34% and regurgitant index decreased by 17%. The change in systemic vascular resistance was related to its initial rest level (r = 0.82, p less than 0.001) and to the changes in forward cardiac output (r = 0.58, p less than 0.01) and regurgitant index (r = 0.60, p less than 0.01). Left ventricular end-diastolic and end-systolic volumes, stroke volume and ejection fraction were unchanged, whereas right ventricular ejection fraction increased. During exercise, nifedipine administration further increased heart rate by 8% and decreased systemic vascular resistance by 19%. Both forward stroke volume and forward cardiac output increased, but total left ventricular stroke volume was unchanged, resulting in a significant decrease in regurgitant index. Although left ventricular end-diastolic volume was slightly decreased, end-systolic volume did not increase; thus, ejection fraction was higher than that during control exercise (p less than 0.01). Right ventricular ejection fraction increased further. In aortic regurgitation, the acute administration of nifedipine improved cardiac performance and reduced regurgitation at rest and during exercise as a result of afterload reduction and increased heart rate. Whether these beneficial effects will occur during long-term therapy requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491083     DOI: 10.1016/s0735-1097(84)80049-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Aortic Regurgitation.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-04

2.  Role of vasodilators in regurgitant valve disease.

Authors:  Artur Evangelista; Pilar Tornos; Antonia Sambola; Gaieta Permayer-Miralda
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12

Review 3.  Valvular heart disease: diagnosis and management.

Authors:  Kameswari Maganti; Vera H Rigolin; Maurice Enriquez Sarano; Robert O Bonow
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

Review 4.  Aortic Regurgitation.

Authors:  Nir Flint; Nina C Wunderlich; Hezzy Shmueli; Sagit Ben-Zekry; Robert J Siegel; Roy Beigel
Journal:  Curr Cardiol Rep       Date:  2019-06-03       Impact factor: 2.931

Review 5.  Are vasodilators still indicated in the treatment of severe aortic regurgitation?

Authors:  Jocelyn Inamo; Maurice Enriquez-Sarano
Journal:  Curr Cardiol Rep       Date:  2007-04       Impact factor: 2.931

Review 6.  Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.